Providers' utilization and perceptions of warfarin dosing algorithms
Warfarin dosing algorithms have proven beneficial in increasing time within therapeutic range (TTR) and decreasing adverse events associated with out-of-range international normalized ratios (INRs). Despite widespread availability, providers' utilization and perceptions of warfarin algorithms i...
Saved in:
| Published in | Thrombosis research Vol. 183; pp. 4 - 12 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Ltd
01.11.2019
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0049-3848 1879-2472 1879-2472 |
| DOI | 10.1016/j.thromres.2019.09.002 |
Cover
| Abstract | Warfarin dosing algorithms have proven beneficial in increasing time within therapeutic range (TTR) and decreasing adverse events associated with out-of-range international normalized ratios (INRs). Despite widespread availability, providers' utilization and perceptions of warfarin algorithms in real-world practice are unclear. Identifying perceptions and barriers to algorithm use may help attempts to improve warfarin therapy management.
Anticoagulation providers' utilization and perceptions of warfarin dosing algorithms were assessed via a nationwide electronic survey.
Of the 246 providers who completed the survey, 82% were pharmacists, and 69% had over five years' experience dosing warfarin. Warfarin dosing algorithms were deemed beneficial by 84% of respondents and 72% currently use a warfarin dosing algorithm in their practice at least occasionally. Pharmacists were least likely of anticoagulation providers to use algorithms, although this was not statistically significant (p = 0.12). Algorithm utilization also decreased as years of warfarin dosing experience increased, with the highest rate of usage noted in the first year of dosing warfarin. The most common reason providers gave for discontinuing algorithm use was that they no longer felt it was needed. In this study, clinic patient volume did not appear to be associated with algorithm utilization.
Warfarin dosing algorithms are frequently used among anticoagulation providers, especially those new to dosing warfarin, but use is frequently not sustained over the long-term. Education on the continued benefits of warfarin dosing algorithms could increase long-term utilization, potentially improving patient outcomes.
•Most providers generally find warfarin dosing algorithms beneficial.•Three out of 4 providers use a warfarin dosing algorithm in their current practice.•Warfarin algorithm utilization declines as years of experience increases.•Warfarin dosing algorithms restricting clinical judgement is a barrier to use. |
|---|---|
| AbstractList | Warfarin dosing algorithms have proven beneficial in increasing time within therapeutic range (TTR) and decreasing adverse events associated with out-of-range international normalized ratios (INRs). Despite widespread availability, providers' utilization and perceptions of warfarin algorithms in real-world practice are unclear. Identifying perceptions and barriers to algorithm use may help attempts to improve warfarin therapy management.
Anticoagulation providers' utilization and perceptions of warfarin dosing algorithms were assessed via a nationwide electronic survey.
Of the 246 providers who completed the survey, 82% were pharmacists, and 69% had over five years' experience dosing warfarin. Warfarin dosing algorithms were deemed beneficial by 84% of respondents and 72% currently use a warfarin dosing algorithm in their practice at least occasionally. Pharmacists were least likely of anticoagulation providers to use algorithms, although this was not statistically significant (p = 0.12). Algorithm utilization also decreased as years of warfarin dosing experience increased, with the highest rate of usage noted in the first year of dosing warfarin. The most common reason providers gave for discontinuing algorithm use was that they no longer felt it was needed. In this study, clinic patient volume did not appear to be associated with algorithm utilization.
Warfarin dosing algorithms are frequently used among anticoagulation providers, especially those new to dosing warfarin, but use is frequently not sustained over the long-term. Education on the continued benefits of warfarin dosing algorithms could increase long-term utilization, potentially improving patient outcomes.
•Most providers generally find warfarin dosing algorithms beneficial.•Three out of 4 providers use a warfarin dosing algorithm in their current practice.•Warfarin algorithm utilization declines as years of experience increases.•Warfarin dosing algorithms restricting clinical judgement is a barrier to use. Warfarin dosing algorithms have proven beneficial in increasing time within therapeutic range (TTR) and decreasing adverse events associated with out-of-range international normalized ratios (INRs). Despite widespread availability, providers' utilization and perceptions of warfarin algorithms in real-world practice are unclear. Identifying perceptions and barriers to algorithm use may help attempts to improve warfarin therapy management. Anticoagulation providers' utilization and perceptions of warfarin dosing algorithms were assessed via a nationwide electronic survey. Of the 246 providers who completed the survey, 82% were pharmacists, and 69% had over five years' experience dosing warfarin. Warfarin dosing algorithms were deemed beneficial by 84% of respondents and 72% currently use a warfarin dosing algorithm in their practice at least occasionally. Pharmacists were least likely of anticoagulation providers to use algorithms, although this was not statistically significant (p = 0.12). Algorithm utilization also decreased as years of warfarin dosing experience increased, with the highest rate of usage noted in the first year of dosing warfarin. The most common reason providers gave for discontinuing algorithm use was that they no longer felt it was needed. In this study, clinic patient volume did not appear to be associated with algorithm utilization. Warfarin dosing algorithms are frequently used among anticoagulation providers, especially those new to dosing warfarin, but use is frequently not sustained over the long-term. Education on the continued benefits of warfarin dosing algorithms could increase long-term utilization, potentially improving patient outcomes. Warfarin dosing algorithms have proven beneficial in increasing time within therapeutic range (TTR) and decreasing adverse events associated with out-of-range international normalized ratios (INRs). Despite widespread availability, providers' utilization and perceptions of warfarin algorithms in real-world practice are unclear. Identifying perceptions and barriers to algorithm use may help attempts to improve warfarin therapy management.INTRODUCTIONWarfarin dosing algorithms have proven beneficial in increasing time within therapeutic range (TTR) and decreasing adverse events associated with out-of-range international normalized ratios (INRs). Despite widespread availability, providers' utilization and perceptions of warfarin algorithms in real-world practice are unclear. Identifying perceptions and barriers to algorithm use may help attempts to improve warfarin therapy management.Anticoagulation providers' utilization and perceptions of warfarin dosing algorithms were assessed via a nationwide electronic survey.METHODSAnticoagulation providers' utilization and perceptions of warfarin dosing algorithms were assessed via a nationwide electronic survey.Of the 246 providers who completed the survey, 82% were pharmacists, and 69% had over five years' experience dosing warfarin. Warfarin dosing algorithms were deemed beneficial by 84% of respondents and 72% currently use a warfarin dosing algorithm in their practice at least occasionally. Pharmacists were least likely of anticoagulation providers to use algorithms, although this was not statistically significant (p = 0.12). Algorithm utilization also decreased as years of warfarin dosing experience increased, with the highest rate of usage noted in the first year of dosing warfarin. The most common reason providers gave for discontinuing algorithm use was that they no longer felt it was needed. In this study, clinic patient volume did not appear to be associated with algorithm utilization.RESULTSOf the 246 providers who completed the survey, 82% were pharmacists, and 69% had over five years' experience dosing warfarin. Warfarin dosing algorithms were deemed beneficial by 84% of respondents and 72% currently use a warfarin dosing algorithm in their practice at least occasionally. Pharmacists were least likely of anticoagulation providers to use algorithms, although this was not statistically significant (p = 0.12). Algorithm utilization also decreased as years of warfarin dosing experience increased, with the highest rate of usage noted in the first year of dosing warfarin. The most common reason providers gave for discontinuing algorithm use was that they no longer felt it was needed. In this study, clinic patient volume did not appear to be associated with algorithm utilization.Warfarin dosing algorithms are frequently used among anticoagulation providers, especially those new to dosing warfarin, but use is frequently not sustained over the long-term. Education on the continued benefits of warfarin dosing algorithms could increase long-term utilization, potentially improving patient outcomes.CONCLUSIONWarfarin dosing algorithms are frequently used among anticoagulation providers, especially those new to dosing warfarin, but use is frequently not sustained over the long-term. Education on the continued benefits of warfarin dosing algorithms could increase long-term utilization, potentially improving patient outcomes. AbstractIntroductionWarfarin dosing algorithms have proven beneficial in increasing time within therapeutic range (TTR) and decreasing adverse events associated with out-of-range international normalized ratios (INRs). Despite widespread availability, providers' utilization and perceptions of warfarin algorithms in real-world practice are unclear. Identifying perceptions and barriers to algorithm use may help attempts to improve warfarin therapy management. MethodsAnticoagulation providers' utilization and perceptions of warfarin dosing algorithms were assessed via a nationwide electronic survey. ResultsOf the 246 providers who completed the survey, 82% were pharmacists, and 69% had over five years' experience dosing warfarin. Warfarin dosing algorithms were deemed beneficial by 84% of respondents and 72% currently use a warfarin dosing algorithm in their practice at least occasionally. Pharmacists were least likely of anticoagulation providers to use algorithms, although this was not statistically significant ( p = 0.12). Algorithm utilization also decreased as years of warfarin dosing experience increased, with the highest rate of usage noted in the first year of dosing warfarin. The most common reason providers gave for discontinuing algorithm use was that they no longer felt it was needed. In this study, clinic patient volume did not appear to be associated with algorithm utilization. ConclusionWarfarin dosing algorithms are frequently used among anticoagulation providers, especially those new to dosing warfarin, but use is frequently not sustained over the long-term. Education on the continued benefits of warfarin dosing algorithms could increase long-term utilization, potentially improving patient outcomes. |
| Author | Witt, Daniel M. Gardner, Trevor Kim, Kibum Vazquez, Sara R. Jones, Aubrey E. |
| Author_xml | – sequence: 1 givenname: Trevor surname: Gardner fullname: Gardner, Trevor organization: University of Utah College of Pharmacy, Department of Pharmacotherapy, University of Utah, 30 South 2000 East Salt, Lake City, UT 84112, United States of America – sequence: 2 givenname: Sara R. orcidid: 0000-0002-9267-8980 surname: Vazquez fullname: Vazquez, Sara R. email: sara.vazquez@hsc.utah.edu organization: University of Utah Health Thrombosis Center, 50 N Medical Drive Room 1R211, Salt Lake City, UT 84132, United States of America – sequence: 3 givenname: Kibum orcidid: 0000-0002-8676-7434 surname: Kim fullname: Kim, Kibum organization: University of Utah College of Pharmacy, Department of Pharmacotherapy, University of Utah, 30 South 2000 East Salt, Lake City, UT 84112, United States of America – sequence: 4 givenname: Aubrey E. surname: Jones fullname: Jones, Aubrey E. organization: University of Utah College of Pharmacy, Department of Pharmacotherapy, University of Utah, 30 South 2000 East Salt, Lake City, UT 84112, United States of America – sequence: 5 givenname: Daniel M. surname: Witt fullname: Witt, Daniel M. organization: University of Utah College of Pharmacy, Department of Pharmacotherapy, University of Utah, 30 South 2000 East Salt, Lake City, UT 84112, United States of America |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31505378$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUl1r3DAQFCWluaT9C8Fv7YuvK8m2bCilIf1IIdBC8y5kaZXoaktXyU5Jf33lXO4lD0lgQSzMzO6M9ogc-OCRkBMKawq0eb9ZT9cxjBHTmgHt1pAL2Auyoq3oSlYJdkBWAFVX8rZqD8lRShsAKmhXvyKHnNZQc9GuyOefMdw4gzG9LebJDe6fmlzwhfKm2GLUuF3aVARb_FXRquh8YUJy_qpQw1WIbroe02vy0qoh4Zv795hcfv1yeXZeXvz49v3s9KLUlWinkkMnRMe5YaJiFcsrWARad0wzhQwFKLC21xxMr3puG9pbzqCqG6yNpYYfk3c72W0Mf2ZMkxxd0jgMymOYk2SsbUWdvdcZenIPnfsRjdxGN6p4K_fGM-DDDqBjSCmildpNd9anqNwgKcglZ7mR-5zlkrOEXMAyvXlA3094kvhpR8Sc043DKJN26DUaF1FP0gT3tMTHBxJ6cN5pNfzGW0ybMEeff0FSmZgE-Wu5guUIaMeBd23zuMBzNvgPqprGkA |
| CitedBy_id | crossref_primary_10_1016_j_tru_2021_100093 crossref_primary_10_1016_j_thromres_2021_10_003 |
| Cites_doi | 10.1007/s11239-015-1319-y 10.1002/phar.1991 10.1111/j.1538-7836.2009.03652.x 10.1016/j.thromres.2014.11.033 10.1001/jama.2017.11469 10.1038/clpt.2008.10 10.1111/j.1468-1331.2012.03772.x 10.1161/STR.0000000000000046 10.1161/CIRCULATIONAHA.112.101808 10.1160/TH11-05-0353 10.1161/STR.0000000000000024 10.1111/j.1538-7836.2008.02959.x 10.1016/j.arth.2009.07.021 10.1016/j.thromres.2012.11.016 |
| ContentType | Journal Article |
| Copyright | 2019 Elsevier Ltd Copyright © 2019 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2019 Elsevier Ltd – notice: Copyright © 2019 Elsevier Ltd. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.thromres.2019.09.002 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1879-2472 |
| EndPage | 12 |
| ExternalDocumentID | 31505378 10_1016_j_thromres_2019_09_002 S0049384819303986 1_s2_0_S0049384819303986 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 3O- 4.4 457 4CK 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K WUQ X7M Z5R ZGI ~G- ~HD 0SF AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ RIG AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c478t-30977933d274242505fe01592c2ae2e70a0ffbc30dbab3f61bf320456e5df1d3 |
| IEDL.DBID | .~1 |
| ISSN | 0049-3848 1879-2472 |
| IngestDate | Thu Oct 02 11:28:14 EDT 2025 Thu Apr 03 07:01:38 EDT 2025 Thu Oct 02 04:26:46 EDT 2025 Thu Apr 24 23:03:50 EDT 2025 Sun Apr 06 06:53:57 EDT 2025 Tue Feb 25 19:58:29 EST 2025 Tue Oct 14 19:36:08 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Warfarin TTR MA Nomogram Perception Barrier LPN INR DOAC Algorithm Provider time within therapeutic range medical assistant international normalized ratio direct oral anticoagulant licensed practical nurse |
| Language | English |
| License | Copyright © 2019 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c478t-30977933d274242505fe01592c2ae2e70a0ffbc30dbab3f61bf320456e5df1d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-9267-8980 0000-0002-8676-7434 |
| PMID | 31505378 |
| PQID | 2288752475 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_2288752475 pubmed_primary_31505378 crossref_citationtrail_10_1016_j_thromres_2019_09_002 crossref_primary_10_1016_j_thromres_2019_09_002 elsevier_sciencedirect_doi_10_1016_j_thromres_2019_09_002 elsevier_clinicalkeyesjournals_1_s2_0_S0049384819303986 elsevier_clinicalkey_doi_10_1016_j_thromres_2019_09_002 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-11-01 |
| PublicationDateYYYYMMDD | 2019-11-01 |
| PublicationDate_xml | – month: 11 year: 2019 text: 2019-11-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Thrombosis research |
| PublicationTitleAlternate | Thromb Res |
| PublicationYear | 2019 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Markel, York, Liston, Flynn, Barnes, Davis, Committee (bb0045) 2010; 25 Van Spall, Wallentin, Yusuf, Eikelboom, Nieuwlaat, Yang, Kabali, Reilly, Ezekowitz, Connolly (bb0080) 2012; 126 Yoo, Kwon, Jo, Kang, Kim (bb0060) 2012; 19 Meschia, Bushnell, Boden-Albala, Braun, Bravata, Chaturvedi, Creager, Eckel, Elkind, Fornage, Goldstein, Greenberg, Horvath, Iadecola, Jauch, Moore, Wilson, American Heart Association Stroke C, Council on C, Stroke N, Council on Clinical C, Council on Functional G, Translational B, Council on H (bb0035) 2014; 45 Poller, Keown, Ibrahim, Lowe, Moia, Turpie, Roberts, van den Besselaar, van der Meer, Tripodi, Palareti, Shiach, Bryan, Samama, Burgess-Wilson, Heagerty, Maccallum, Wright, Jespersen (bb0065) 2008; 6 Rosenman, Liu, Phatak, Qi, Teal, Nisi, Liu, Parr (bb0050) 2016; 23 Jeffrey WI. Oral anticoagulants 2011. In: Goodman and Gilman's: The Pharmacological Basis of Therapeutics [Internet]. (12th. [17–25]. Available from) Gage, Bass, Lin, Woller, Stevens, Al-Hammadi, Li, Rodriguez, Miller, GA, Pendleton, Jaffer, King, Whipple, Porche-Sorbet, Napoli, Merritt, Thompson, Hyun, Anderson, Hollomon, Barrack, Nunley, Moskowitz, Davila-Roman, Eby (bb0020) 2017; 318 Gallagher, Setakis, Plumb, Clemens, van Staa (bb0010) 2011; 106 Mohammad, Korkis, Garwood (bb0055) 2017; 37 bb0085 Kim, Nieuwlaat, Connolly, Schulman, Meijer, Raju, Kaatz, Eikelboom (bb0075) 2010; 8 . Cho, Delate, Witt, Clark (bb0040) 2015; 135 Gage, Eby, Johnson, Deych, Rieder, Ridker, Milligan, Grice, Lenzini, Rettie, Aquilante, Grosso, Marsh, Langaee, Farnett, Voora, Veenstra, Glynn, Barrett, McLeod (bb0025) 2008; 84 Witt, Clark, Kaatz, Schnurr, Ansell (bb0015) 2016; 41 Kernan, Ovbiagele, Black, Bravata, Chimowitz, Ezekowitz, Fang, Fisher, Furie, Heck, Johnston, Kasner, Kittner, Mitchell, Rich, Richardson, Schwamm, Wilson, American Heart Association Stroke Council CoC, Stroke Nursing CoCC, Council on Peripheral Vascular D (bb0030) 2014; 45 Grzymala-Lubanski, Sjalander, Renlund, Svensson, Sjalander (bb0070) 2013; 131 Van Spall (10.1016/j.thromres.2019.09.002_bb0080) 2012; 126 Yoo (10.1016/j.thromres.2019.09.002_bb0060) 2012; 19 Witt (10.1016/j.thromres.2019.09.002_bb0015) 2016; 41 Grzymala-Lubanski (10.1016/j.thromres.2019.09.002_bb0070) 2013; 131 Kernan (10.1016/j.thromres.2019.09.002_bb0030) 2014; 45 10.1016/j.thromres.2019.09.002_bb0005 Gage (10.1016/j.thromres.2019.09.002_bb0025) 2008; 84 Meschia (10.1016/j.thromres.2019.09.002_bb0035) 2014; 45 Poller (10.1016/j.thromres.2019.09.002_bb0065) 2008; 6 Kim (10.1016/j.thromres.2019.09.002_bb0075) 2010; 8 Cho (10.1016/j.thromres.2019.09.002_bb0040) 2015; 135 Gage (10.1016/j.thromres.2019.09.002_bb0020) 2017; 318 Gallagher (10.1016/j.thromres.2019.09.002_bb0010) 2011; 106 Mohammad (10.1016/j.thromres.2019.09.002_bb0055) 2017; 37 Markel (10.1016/j.thromres.2019.09.002_bb0045) 2010; 25 Rosenman (10.1016/j.thromres.2019.09.002_bb0050) 2016; 23 |
| References_xml | – volume: 131 start-page: 130 year: 2013 end-page: 134 ident: bb0070 article-title: Computer aided warfarin dosing in the Swedish national quality registry AuriculA - algorithmic suggestions are performing better than manually changed doses publication-title: Thromb. Res. – volume: 318 start-page: 1115 year: 2017 end-page: 1124 ident: bb0020 article-title: Effect of genotype-guided warfarin dosing on clinical events and anticoagulation control among patients undergoing hip or knee arthroplasty: the GIFT randomized clinical trial publication-title: JAMA – volume: 106 start-page: 968 year: 2011 end-page: 977 ident: bb0010 article-title: Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients publication-title: Thromb. Haemost. – volume: 126 start-page: 2309 year: 2012 end-page: 2316 ident: bb0080 article-title: Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial publication-title: Circulation. – volume: 135 start-page: 267 year: 2015 end-page: 271 ident: bb0040 article-title: Thromboembolic and bleeding outcomes of extended duration low-intensity warfarin following elective total knee arthroplasty publication-title: Thromb. Res. – ident: bb0085 article-title: REDCap [11/12/2018] – reference: Jeffrey WI. Oral anticoagulants 2011. In: Goodman and Gilman's: The Pharmacological Basis of Therapeutics [Internet]. (12th. [17–25]. Available from) – volume: 41 start-page: 187 year: 2016 end-page: 205 ident: bb0015 article-title: Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism publication-title: J. Thromb. Thrombolysis – reference: . – volume: 19 start-page: 1547 year: 2012 end-page: 1553 ident: bb0060 article-title: Age- and weight-adjusted warfarin initiation nomogram for ischaemic stroke patients publication-title: Eur. J. Neurol. – volume: 45 start-page: 3754 year: 2014 end-page: 3832 ident: bb0035 article-title: Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association publication-title: Stroke. – volume: 37 start-page: 1284 year: 2017 end-page: 1297 ident: bb0055 article-title: Incorporating comprehensive management of direct oral anticoagulants into anticoagulation clinics publication-title: Pharmacotherapy. – volume: 23 year: 2016 ident: bb0050 article-title: Pharmacologic prophylaxis for venous thromboembolism among patients with total joint replacement: an electronic medical records study publication-title: Am. J. Ther. – volume: 6 start-page: 935 year: 2008 end-page: 943 ident: bb0065 article-title: An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage publication-title: J. Thromb. Haemost. – volume: 8 start-page: 101 year: 2010 end-page: 106 ident: bb0075 article-title: Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study publication-title: J. Thromb. Haemost. – volume: 84 start-page: 326 year: 2008 end-page: 331 ident: bb0025 article-title: Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin publication-title: Clin. Pharmacol. Ther. – volume: 45 start-page: 2160 year: 2014 end-page: 2236 ident: bb0030 article-title: Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association publication-title: Stroke. – volume: 25 year: 2010 ident: bb0045 article-title: Venous thromboembolism: management by American Association of Hip and Knee Surgeons publication-title: J. Arthroplast. – volume: 41 start-page: 187 issue: 1 year: 2016 ident: 10.1016/j.thromres.2019.09.002_bb0015 article-title: Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism publication-title: J. Thromb. Thrombolysis doi: 10.1007/s11239-015-1319-y – volume: 37 start-page: 1284 issue: 10 year: 2017 ident: 10.1016/j.thromres.2019.09.002_bb0055 article-title: Incorporating comprehensive management of direct oral anticoagulants into anticoagulation clinics publication-title: Pharmacotherapy. doi: 10.1002/phar.1991 – volume: 8 start-page: 101 issue: 1 year: 2010 ident: 10.1016/j.thromres.2019.09.002_bb0075 article-title: Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study publication-title: J. Thromb. Haemost. doi: 10.1111/j.1538-7836.2009.03652.x – volume: 135 start-page: 267 issue: 2 year: 2015 ident: 10.1016/j.thromres.2019.09.002_bb0040 article-title: Thromboembolic and bleeding outcomes of extended duration low-intensity warfarin following elective total knee arthroplasty publication-title: Thromb. Res. doi: 10.1016/j.thromres.2014.11.033 – ident: 10.1016/j.thromres.2019.09.002_bb0005 – volume: 318 start-page: 1115 issue: 12 year: 2017 ident: 10.1016/j.thromres.2019.09.002_bb0020 article-title: Effect of genotype-guided warfarin dosing on clinical events and anticoagulation control among patients undergoing hip or knee arthroplasty: the GIFT randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2017.11469 – volume: 84 start-page: 326 issue: 3 year: 2008 ident: 10.1016/j.thromres.2019.09.002_bb0025 article-title: Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.2008.10 – volume: 23 issue: 2 year: 2016 ident: 10.1016/j.thromres.2019.09.002_bb0050 article-title: Pharmacologic prophylaxis for venous thromboembolism among patients with total joint replacement: an electronic medical records study publication-title: Am. J. Ther. – volume: 19 start-page: 1547 issue: 12 year: 2012 ident: 10.1016/j.thromres.2019.09.002_bb0060 article-title: Age- and weight-adjusted warfarin initiation nomogram for ischaemic stroke patients publication-title: Eur. J. Neurol. doi: 10.1111/j.1468-1331.2012.03772.x – volume: 45 start-page: 3754 issue: 12 year: 2014 ident: 10.1016/j.thromres.2019.09.002_bb0035 article-title: Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association publication-title: Stroke. doi: 10.1161/STR.0000000000000046 – volume: 126 start-page: 2309 issue: 19 year: 2012 ident: 10.1016/j.thromres.2019.09.002_bb0080 publication-title: Circulation. doi: 10.1161/CIRCULATIONAHA.112.101808 – volume: 106 start-page: 968 issue: 5 year: 2011 ident: 10.1016/j.thromres.2019.09.002_bb0010 article-title: Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients publication-title: Thromb. Haemost. doi: 10.1160/TH11-05-0353 – volume: 45 start-page: 2160 issue: 7 year: 2014 ident: 10.1016/j.thromres.2019.09.002_bb0030 article-title: Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association publication-title: Stroke. doi: 10.1161/STR.0000000000000024 – volume: 6 start-page: 935 issue: 6 year: 2008 ident: 10.1016/j.thromres.2019.09.002_bb0065 article-title: An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage publication-title: J. Thromb. Haemost. doi: 10.1111/j.1538-7836.2008.02959.x – volume: 25 issue: 1 year: 2010 ident: 10.1016/j.thromres.2019.09.002_bb0045 article-title: Venous thromboembolism: management by American Association of Hip and Knee Surgeons publication-title: J. Arthroplast. doi: 10.1016/j.arth.2009.07.021 – volume: 131 start-page: 130 issue: 2 year: 2013 ident: 10.1016/j.thromres.2019.09.002_bb0070 article-title: Computer aided warfarin dosing in the Swedish national quality registry AuriculA - algorithmic suggestions are performing better than manually changed doses publication-title: Thromb. Res. doi: 10.1016/j.thromres.2012.11.016 |
| SSID | ssj0017195 |
| Score | 2.2706852 |
| Snippet | Warfarin dosing algorithms have proven beneficial in increasing time within therapeutic range (TTR) and decreasing adverse events associated with out-of-range... AbstractIntroductionWarfarin dosing algorithms have proven beneficial in increasing time within therapeutic range (TTR) and decreasing adverse events... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 4 |
| SubjectTerms | Adult Algorithm Algorithms Barrier Cross-Sectional Studies Female Health Personnel - standards Hematology, Oncology, and Palliative Medicine Humans Male Nomogram Perception Provider Warfarin Warfarin - pharmacology Warfarin - therapeutic use |
| Title | Providers' utilization and perceptions of warfarin dosing algorithms |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0049384819303986 https://www.clinicalkey.es/playcontent/1-s2.0-S0049384819303986 https://dx.doi.org/10.1016/j.thromres.2019.09.002 https://www.ncbi.nlm.nih.gov/pubmed/31505378 https://www.proquest.com/docview/2288752475 |
| Volume | 183 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1879-2472 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017195 issn: 0049-3848 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals customDbUrl: eissn: 1879-2472 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017195 issn: 0049-3848 databaseCode: AIKHN dateStart: 20160601 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect (Elsevier) customDbUrl: eissn: 1879-2472 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017195 issn: 0049-3848 databaseCode: ACRLP dateStart: 20160601 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect (Elsevier) customDbUrl: eissn: 1879-2472 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017195 issn: 0049-3848 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1879-2472 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017195 issn: 0049-3848 databaseCode: AKRWK dateStart: 19720201 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3daxQxEB9KBfFF_PZaLREEn7aXTbKby2OpllNp8aFC30I-9cp197i94lv_die72VNRURT2ZZcMWYbJfGTmNwPwUlaGo1XmhZOOF8JzVRghfIERM_U0Um_7DP7pWT3_KN5dVBc7cDxiYVJZZdb9g07vtXX-Ms3cnK4Wi4TxFYqnbvAK1bCapbbbQsg0xeDwZlvmUcpSDVMMhCrS6u9QwpeHaRTBFYa1qcRL9f1O8_XKLwzU7xzQ3hCd3IO72YMkR8NP3oed0DyA26c5R_4QXn_I4LruFUGpWmagJTGNJ6tvZSykjeSLWUeMlRvi23RlQMzyU7tebD5fdY_g_OTN-fG8yLMSCifkbFNwio6c4tyn1KtIfk0MaOkVc8wEFiQ1NEbrODLfWB7r0kaeOtHXofKx9Pwx7DZtE54CwQDN1nHGAmdcVCxa1UdhtbW1c1K6CVQjf7TLfcTTOIulHgvGLvXIV534qik-lE1guqVbDZ00_kghR_brESeKmk2jsv83ytDlA9rpUndMU_2TEE1AbSl_kMO_2vXFKCMaD2nKvJgmtNe4iKEur5iQ1QSeDMKz5QFHl7zicrb3Hzvvw530NmAkn8HuZn0dnqOztLEH_Wk4gFtHb9_Pz74C5NAT4w |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jj9MwFH4aBgm4INaZshoJiVOmie3E9RHNogLTEYcizc3yCh11kqrpiBu_nefEKSBAIJBySvzk6NPzW_w2gJei1Ay1MsussCzjjslMc-4y9Jhzl4fcmS6CPzurph_42_PyfAcOh1qYmFaZZH8v0ztpnd6ME5rj1WIRa3y5ZLEbvEQxLCfVNbjOSyqiB3bwZZvnUYhC9mMMuMzi8u_KhC8O4iyCS_RrY46X7BqepvuVX2io31mgnSY6uQO3kwlJXvd_eRd2fH0PbsxSkPw-HL1P1XXtK4JstUyVlkTXjqy-5bGQJpDPeh3QWa6Ja-KdAdHLj816sfl02T6A-cnx_HCapWEJmeVisslYjpacZMzF2CuPhk3wqOoltVR76kWu8xCMZYi-NixUhQkstqKvfOlC4dhD2K2b2u8DQQ_NVGFCPaMMAQ1Gdm5YZUxlrRB2BOWAj7KpkXicZ7FUQ8bYhRpwVRFXleOT0xGMt3SrvpXGHynEAL8aCkVRtCmU9v9G6dt0QltVqJaqXP3ERSOQW8ofGPGvdn0x8IjCUxpDL7r2zRUuoijMS8pFOYK9nnm2GDC0yUsmJo_-Y-fncHM6n52q0zdn7x7DrfilL5h8Arub9ZV_ipbTxjzrTsZXH9gVeA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Providers%27+utilization+and+perceptions+of+warfarin+dosing+algorithms&rft.jtitle=Thrombosis+research&rft.au=Gardner%2C+Trevor&rft.au=Vazquez%2C+Sara+R&rft.au=Kim%2C+Kibum&rft.au=Jones%2C+Aubrey+E&rft.date=2019-11-01&rft.eissn=1879-2472&rft.volume=183&rft.spage=4&rft_id=info:doi/10.1016%2Fj.thromres.2019.09.002&rft_id=info%3Apmid%2F31505378&rft.externalDocID=31505378 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0049-3848&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0049-3848&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0049-3848&client=summon |